Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 27, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Type 2 Diabetes can be triggered by Prolonged Use of Common Acid Reflux Drugs

Maharashtra: Palghar under alert due to rise of congo fever

Phylloid-type pigmentary | mosaicism and ambiguous genitalia | trisomy 14 | der(Y)t(Y;14)

Type 2 Diabetes can be triggered by Prolonged Use of Common Acid Reflux Drugs
  • BiotechToday
  • World

Type 2 Diabetes can be triggered by Prolonged Use of Common Acid Reflux Drugs

bioxone September 30, 2020September 30, 2020

-Team bioXone

Research by an international team of scientists suggested that regular use of proton pump inhibitors (PPIs), commonly used to treat acid reflux, are related to a heightened risk of developing type 2 diabetes. The results also indicated that with the duration of PPI use, this risk of type 2 diabetes increases; prompting the researchers to advise people who take these drugs for more than 2 years should do regular blood glucose check-ups to be alert from diabetes.

PPIs are commonly used worldwide to treat peptic ulcers, acid reflux, and indigestion. While it is generally accepted that usage of PPIs for the short term is safe, yet long-term usage has been linked to an increased risk of chronic kidney disease, bone fractures, and stomach cancer. Recent studies also indicated that PPIs could affect gut microbes.

In deep-analysis showed that diabetes risk among PPI users wasn’t affected by age, sex, smoking, alcohol intake, family history of diabetes, high cholesterol,  diet, physical activity, or regular use of anti-inflammatory drugs. But it was found higher among participants who were not overweight and had normal blood pressure.

A good amount of evidence suggests that alterations in the type/ volume of bacteria in the gut (the microbiome) may help explain the linkage found between PPI use and an increased risk of developing diabetes.

Scientists conclude that the varied range of side effects also with the heightened risk of diabetes is made to be cured by prescribing PPI drugs; in any case, clinical practitioners should carefully assess the pros and cons before prescribing any related PPI medication.

Citation: https://www.miragenews.com/regular-use-of-acid-reflux-drugs-linked-to-heightened-risk-of-type-2-diabetes/

Read more about biosciences on bioXone.in

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged blood glucose PPI proton pump inhibitors Type 2 diabetes

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Phylloid-type pigmentary | mosaicism and ambiguous genitalia | trisomy 14 | der(Y)t(Y;14)

bioxone September 30, 2020

-Husna, Amity University Kolkata Trisomy 14 is an aneusomy that is viable with life if present in a mosaic individual. Mostly, the symptoms are prenatal and postnatal growth failure, genitourinary and ear abnormalities, congenital heart defects, developmental delay, narrow palpebral fissures, broad nose, short jaw, and short neck. A clinical survey on 51 patients showed […]

Related Post

  • BiotechToday
  • World

Antibodies against Nipah Virus found in Mahabaleshwar bats

bioxone June 24, 2021June 23, 2021

Akshita Kumar, M.Sc. Biochemistry A recent study jointly conducted by the Indian Council of Medical Research(ICMR) and the National Institute of Virology(NIV) detected the presence of antibodies against Nipah virus(NiV) in bats residing in a cave in Mahabaleshwar. The sole purpose of this study was to investigate the spread of the Nipah Virus in Indian […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Clinical Chemistry Analyzer in Laboratory Setting

bioxone November 24, 2020November 24, 2020

Sagnik Nag, Amity University Kolkata On November 18, 2020, the Medica EasyRA benchtop clinical chemistry analyzer was distributed and serviced by Greensboro-based company, which provides healthcare officials and staff to keep a routine test on blood chemistries to include and check metabolic activity profiles, liver enzymes, proper kidney functioning glucose levels, and cardiovascular tests. These […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India

Big breakthrough! ICMR and BIOLOGICAL E LTD develop a potential treatment for Covid-19

bioxone October 2, 2020October 2, 2020

-Aishila Kar, Amity University Kolkata The Indian Council of Medical Research (ICMR) in partnership with Hyderabad-based vaccine maker Biological E, has developed a “highly purified antisera” which will be utilized in the prevention and treatment of Covid-19. Antisera are blood sera that carry antibodies against a selected viral toxin or antigen and are introduced to […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy